Subscribe to Drug Discovery & Development for your weekly roundup of the latest strategies & technologies related to biopharma, #biotech, cell & gene therapy, and pharmaceutical R&D: https://lnkd.in/ej8fwqV8
Drug Discovery & Development
图书期刊出版业
Cleveland,Ohio 5,077 位关注者
Strategies and technologies driving drug discovery to market.
关于我们
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation. We report on innovative drug introductions and promising pipeline candidates from Big Pharma and smaller players, as well as relevant clinical trial trends. The publication also covers promising technological developments relevant to the biotech, biopharma and pharma industries, including advances in artificial intelligence, genomic/proteomic sequencing and microscopy. Other areas of focus include orphan drugs, drug advances for oncology, neurological disease and infectious disease including vaccines and other therapies for COVID-19. Our content includes staff-written articles as well as contributed content from experts. The publication serves the pharmaceutical, biopharmaceutical and biotechnology industries, contract research organizations, government laboratories, universities, hospitals, medical centers and others within the life science marketplace. Our readers include informatics specialists, staff scientists, research scientists, corporate and lab management and scientists conducting and leading research within the field. Drug Discovery and Development is a MassDevice-affiliated pharmaceutical industry news website, owned by Cleveland-based WTWH Media. We stand by journalistic ethics to provide the most up-to-date, accurate and fairly reported information for our readers. Sign up for our newsletter: https://www.drugdiscoverytrends.com/enews-signup/ For advertising inquiries, visit our Media Guide: https://marketing.wtwhmedia.com/2023-pharma-media-guide
- 网站
-
https://www.drugdiscoverytrends.com/
Drug Discovery & Development的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 51-200 人
- 总部
- Cleveland,Ohio
- 类型
- 私人持股
- 领域
- Drug Discovery、Drug Development、Pharmaceutical Research、Pharmaceutical Development、Drug Formulation、Drug Introduction、Big Pharma、Clinical Trials、Drug Advances、Oncology、Neurological Disease 、Infectious Disease、Vaccines、COVID-19、Therapies、BioPharma、BioTech、Research、Life Sciences、Technology、Genomics、Artificial Intelligence、Proteomics、Small Molecule Drugs、Orphan Drugs、Corporate Management、Lab Management、Informatics Specialists、Staff Scientists、Research Scientists、Pharma、Government Laboratories、Universities、Hospitals、Medical Centers、Contract Research Organizations、Biotechnology、Biopharmaceuticals、Pharmaceuticals、Drug Discovery News、Drug Discovery Industry、Drug Development News、Drug Development Industry、Drug Discovery Publishing、Drug Development Publishing、Drug Discovery Coverage、Drug Development Coverage和Drug Discovery and Development News
地点
-
主要
1111 Superior Ave
#2600
US,Ohio,Cleveland,44114
Drug Discovery & Development员工
-
Anima Ghosal
Drug Metabolism Expert | Enzymology | CYP450
-
Vincent Santarelli
Project Team Leadership | Early and Late Discovery | Clinical Delivery | Translatable Assay Development | Clinical Experimental Medicine | Ph2 Study…
-
Chris Newmarker
Editor in Chief of MassDevice, Medical Design & Outsourcing and other Life Sciences publications at WTWH Media | Supporting life sciences innovation…
-
Brian K. Buntz
Editor-in-Chief, R&D World @ WTWH Media LLC | Data-Driven Storyteller
动态
-
Drug Discovery & Development转发了
Had the pleasure of learning about lab automation at NVIDIA GTC's healthcare and life science pavilion, catching up with Ginkgo Bioworks, Inc.' GM and VP Will Serber at NVIDIA's GTC to see their "LEGO-like" lab automation system in action. These Reconfigurable Automation Carts (RACs) are creating structured data for AI analysis while human scientists focus on bigger questions. Think of how AI is helping streamline coding. A similar trend could come to the lab where humans focus more on the overall structure of the task (here, an experiment). Oh, and the RACs can snap together similar to LEGOs. It is a bit slower than pressing two blocks together but not by much — only taking about 10 minutes.
-
-
Call for Nominations! ?? The 2025 R&D 100 Awards, known as the “Oscars of Innovation,” is now accepting submissions! Explore the categories and submission process, and submit your entry today: https://lnkd.in/enkp-i3N #RD100 #Research #DrugDiscovery | R&D - Research & Development World
-
-
Drug Discovery & Development转发了
?? ?? Wicked excited to be heading up to Boston next week for #PITTCON 2025! From March 3-5, I’ll be diving into all things laboratory science??, representing WTWH Media’s R&D - Research & Development World, Drug Discovery & Development, and Pharmaceutical Processing World. ?? Have you launched any new products in 2024? Let’s talk about how you can nominate your innovation??for the 2025 R&D 100 Awards—a chance to showcase your breakthrough in front of a global audience of researchers and industry leaders. Looking to get your brand in front of the right decision-makers in your key markets? We can help! Drop a comment or message me if you’ll be there—let’s grab some Dunks ? and chat! #PITTCON2025 #Innovation #RD100Awards #LabScience #Biotech #Pharma
-
-
Subscribe to Drug Discovery & Development for your weekly roundup of the latest strategies & technologies related to biopharma, #biotech, cell & gene therapy, and pharmaceutical R&D: https://lnkd.in/ej8fwqV8
-
-
Drug Discovery & Development转发了
Just posted a new article form Stuart Ward of IDBS titled "How to know if your biopharma company is ‘data ready’ and why it matters" on Drug Discovery & Development Here's a quick summary -- full article available via a link in the comments: The Problem: Many biopharma companies store data without a clear plan for future use, hindering AI potential. The Analogy: Ancient Scrolls.?Like deciphering ancient scrolls, deciphering old data requires effort and the right tools. AI's Untapped Potential:?AI and Machine Learning can extract new meaning from existing biopharma data, potentially paving the way for savings in time and money on in silico experiments. The Strategy: "AI-Ready" Data.?Focus on complete, consistent, and contextualized data capture. 1. Capture Enough Data: Don't be selective with the data.?Even negative and null results are crucial for AI training. 2. Capture All Details: Track everything.?Record experimental conditions, sample lineage, instrument details, and any data restrictions. 3. Use a Consistent Format: Standardize formats.?Enforce consistent naming conventions and data entry protocols. Invest in Systems:?Implement connected instruments, standardized forms, and relational databases to ensure data accuracy and ease of access. Cultivate a Data-First Culture:?Reinforce data stewardship as a company-wide norm.
-
-
Drug Discovery & Development转发了
Dr. Jonathan Graf of University of California, San Francisco - School of Medicine and our Chief Medical Officer Dr. Paul F Lizzul late last year spoke with Brian K. Buntz on shifting the treatment paradigm in #RheumatoidArthritis with PD-1 agonists to restore immune homeostasis. Read more at Drug Discovery & Development: https://bit.ly/49Joki1
-
-
Subscribe to Drug Discovery & Development for your weekly roundup of the latest strategies & technologies related to biopharma, #biotech, cell & gene therapy, and pharmaceutical R&D: https://lnkd.in/ej8fwqV8
-
-
Drug Discovery & Development转发了
American Association of Pharmaceutical Scientists (AAPS) | @aapscomms announces lineup for the 2025 National Biotechnology Conference (NBC) American Association of Pharmaceutical Scientists (AAPS) has announced that the program for its?National Biotechnology Conference (NBC)?is now available.?The full agenda?for the event, which will take place from May 4–7, 2025, spans a combination of live and pre-recorded sessions. The event will convene biopharma scientists, researchers, and industry professionals from around the globe. Attendees will have the opportunity to learn about the latest developments in biotherapeutics, drug delivery, and bioanalysis, all organized under two primary themes: “From Bench to Bedside” and “Inspiring Innovation.”